FDA Clocks Review Time for Gooey 'Chocolate Touch' Heart Balloon
Published Date: 7/2/2025
Notice
Summary
The FDA has set the official review period for CHOCOLATE TOUCH, a special medical balloon catheter coated with paclitaxel. This means the company can apply to extend their patent, giving them more time to protect their invention and possibly earn more money. If you’re in the medical device world, keep an eye on this patent extension process—it could affect competition and innovation timing.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Patent Extension Application Allowed
The FDA determined the regulatory review period for CHOCOLATE TOUCH (a paclitaxel-coated PTA balloon catheter). The company that submitted the device can apply to the U.S. Patent and Trademark Office for an extension of a patent that claims this medical device, which would give the company more time to protect the invention.
May Affect Competition and Innovation Timing
The notice says the patent extension process for CHOCOLATE TOUCH could affect competition and the timing of innovation in the medical device world. Stakeholders in the medical device industry should watch the patent extension because it could change when competitors can enter the market.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in